Thylakoid Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.75 M
as on 17-11-2024
- Revenue 32.24%
(FY 2023)
- Profit -45.50%
(FY 2023)
- Ebitda 0.78%
(FY 2023)
- Net Worth 36.05%
(FY 2023)
- Total Assets 39.48%
(FY 2023)
About Thylakoid Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.75 M.
Jimmeshkumar Patel, Manishkumar Patel, Anandkumar Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100GJ2015PTC083842
- Company No.
083842
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 2015
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationGandhinagar, Gujarat
- Telephone
- Email Address
- Website
- Social Media
What products or services does Thylakoid Biotech Private Limited offer?
Thylakoid Biotech Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Fertilizer, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Vegetable Seeds, Moringa Seeds, Dry Leaves, Moringa Dried Leaves, Cooking Spices and Masala, Whole Spices.
Who are the key members and board of directors at Thylakoid Biotech?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jimmeshkumar Patel | Director | 13-Jul-2015 | Current |
Anandkumar Patel | Director | 13-Jul-2015 | Current |
Manishkumar Patel | Director | 13-Jul-2015 | Current |
Tushar Takoliya | Director | 04-May-2019 | Current |
Financial Performance of Thylakoid Biotech.
Thylakoid Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.24% increase. The company also saw a substantial fall in profitability, with a 45.5% decrease in profit. The company's net worth Soared by an impressive increase of 36.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Thylakoid Biotech?
In 2023, Thylakoid Biotech had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Fuente Pharma Private LimitedActive 4 years 11 months
Jimmeshkumar Patel and Tushar Takoliya are mutual person
- Ramnath Naturals Private LimitedActive 7 years 9 months
Manishkumar Patel and Anandkumar Patel are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Canara Bank Creation Date: 22 Oct 2021 | ₹8.75 M | Open |
How Many Employees Work at Thylakoid Biotech?
Unlock and access historical data on people associated with Thylakoid Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thylakoid Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thylakoid Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.